ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Trifluoroacetic acid → 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-(2-(pyridin-3-ylamino)ethylamino)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid

HRID 85678
印刷

反応式

HRID 85678 の反応式
Br[C:2]1[CH:3]=[N:4][CH:5]=[CH:6][CH:7]=1.CC(C)([O-])C.[Na+].C1COCC1.Cl.Cl.[NH2:21][CH2:22][CH2:23][NH:24][C@:25]12[CH2:60][CH2:59][C@@H:58]([C:61]([CH3:63])=[CH2:62])[C@@H:26]1[C@@H:27]1[C@@:40]([CH3:43])([CH2:41][CH2:42]2)[C@@:39]2([CH3:44])[C@@H:30]([C@:31]3([CH3:57])[C@@H:36]([CH2:37][CH2:38]2)[C:35]([CH3:46])([CH3:45])[C:34]([C:47]2[CH:56]=[CH:55][C:50]([C:51]([O:53]C)=[O:52])=[CH:49][CH:48]=2)=[CH:33][CH2:32]3)[CH2:29][CH2:28]1.O.[OH-].[Li+].C(O)(C(F)(F)F)=O>COCCOC.C([O-])(=O)C.[Pd+2].C([O-])(=O)C.CO.O>[CH3:43][C@:40]12[C@@:39]3([CH3:44])[C@@H:30]([C@:31]4([CH3:57])[C@@H:36]([CH2:37][CH2:38]3)[C:35]([CH3:45])([CH3:46])[C:34]([C:47]3[CH:56]=[CH:55][C:50]([C:51]([OH:53])=[O:52])=[CH:49][CH:48]=3)=[CH:33][CH2:32]4)[CH2:29][CH2:28][C@@H:27]1[C@H:26]1[C@H:58]([C:61]([CH3:63])=[CH2:62])[CH2:59][CH2:60][C@:25]1([NH:24][CH2:23][CH2:22][NH:21][C:2]1[CH:3]=[N:4][CH:5]=[CH:6][CH:7]=1)[CH2:42][CH2:41]2
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

11

反応物 6

HCID 6422Trifluoroacetic acidHCID 8028TetrahydrofuranHCID 122863-BromopyridineHCID 168937Lithium hydroxide, monohydrateHCID 23676156Sodium t-butoxideHCID 131731915methyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(2-amino ethylamino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate bis HCl salt

生成物 1

HCID 683582194-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-(2-(pyridin-3-ylamino)ethylamino)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid収率 82.4%

試薬・触媒・溶媒 4

HCID 167845palladium(II) acetate触媒HCID 887Methanol溶媒HCID 962Water溶媒HCID 80711,2-Dimethoxyethane溶媒2 回

反応条件

温度
110 °C

実験手順

In a 1 dram vial under nitrogen were combined (2R)-1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)ferrocene (CAS#158923-11-6) (2.101 mg, 3.79 mmol), palladium(II) acetate (0.851 mg, 3.79 mmol) and dry DME (0.5 ml). The contents of the vial were stirred for 10 min, and were then added all at once to a separate mixture of 3-bromopyridine (0.014 g, 0.091 mmol) and sodium tert-butoxide, 2.0M solution in THF (0.167 mL, 0.333 mmol) in dry DME (0.333 mL) contained in a separate 1 dram vial. The resulting mixture was allowed to stir very briefly (1 min) before solid methyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(2-aminoethylamino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate bis HCl salt (0.050 g, 0.076 mmol) was added in one portion. The mixture was heated to 110° C. overnight. To the mixture was added lithium hydroxide monohydrate (6.4 mg, 0.152 mmol) with water (0.2 mL) and methanol (0.5 mL) and the resulting mixture was stirred for 4 days. Purification of the crude mixture by reverse phase preparative HPLC using Prep HPLC Method 7 gave the title compound (0.0407 g, 57.5% yield) as a beige powder bis TFA salt. LCMS: m/e 650.4 (M+H)+, 2.26 min (method 11). 1H NMR (500 MHz, 1:1 mixture of CDCl3 and MeOD, MeOD lock) δ ppm 8.26 (d, J=2.4 Hz, 1H), 8.02 (d, J=4.9 Hz, 1H), 7.94-7.87 (m, J=8.2 Hz, 2H), 7.77 (dd, J=8.9, 1.5 Hz, 1H), 7.67 (dd, J=8.9, 5.2 Hz, 1H), 7.22-7.14 (m, 2H), 5.28 (dd, J=6.3, 1.7 Hz, 1H), 4.82 (s, 1H), 4.74 (s, 1H), 3.89-3.78 (m, 1H), 3.70 (dt, J=14.6, 4.5 Hz, 1H), 3.30-3.23 (m, 2H), 2.85 (td, J=11.1, 5.5 Hz, 1H), 2.21-2.05 (m, 3H), 2.03-1.94 (m, 2H), 1.94-1.85 (m, 1H), 1.85-1.76 (m, 1H), 1.72 (s, 3H), 1.70-1.64 (m, 1H), 1.64-1.51 (m, 3H), 1.51-1.44 (m, 3H), 1.43-1.20 (m, 6H), 1.19-1.08 (m, 2H), 1.07-1.04 (m, 3H), 1.04-1.00 (m, 3H), 0.99 (s, 3H), 0.95-0.88 (m, 7H).

後処理

  1. additionwere then added all at
  2. additionwas added in one portion
  3. stirringthe resulting mixture was stirred for 4 days
  4. customPurification of the crude mixture by reverse phase preparative HPLC

出典と根拠

ORDレコード
ord-7118a8a31248428ebc8af8880c0f714d
出典データセット
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08846647B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート